Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-9

  Xu, He N ^a   Zheng, Gang ^b   Tchou, Julia ^a,c   Nioka, Shoko ^a   Li, Lin Z ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

FAD; Flavoprotein (Fp); Glucose uptake; MCF 7; MDA MB 231; MDA MB 468; Mitochondrial redox state; NADH; Pyro 2DG; Redox scanning; The Chance redox scanner

Indexed keywords

EID: 84876530018     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-73     Document Type: Article

References (39)

1. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A, Medina D (2008) Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14(2):370-378
2. Anders C, Carey LA (2008) Understanding and treating triple-negative breast cancer. Oncology (Williston Park) 22(11):1233-1239, discussion 1239-1240, 1243
3. Bartholomeusz C, Gonzalez-Angulo AM, Kazansky A, Krishnamurthy S, Liu P, Yuan LXH, Yamasaki F, Liu S, Hayashi N, Zhang D, Esteva FJ, Hortobagyi GN, Ueno NT (2010) PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin Cancer Res 16(6):1802-1811
4. Bradley DP, Tessier JJ, Ashton SE, Waterton JC, Wilson Z, Worthington PL, Ryan AJ (2007) Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats. Neoplasia 9(5):382-391
5. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2):85
6. Chance B, Baltscheffsky H (1958) Respiratory enzymes in oxidative phosphorylation. VII. Binding of intramitochondrial reduced pyridine nucleotide. J Biol Chem 233(3):736-739
7. Chance B, Schoener B (1966) High and low energy states of cytochromes. J Biol Chem 241(20):4567-4573
8. Chance B, Williams GR (1955) Simple and rapid assay of oxidative phosphorylation. Nature 175(4469):1120-1121
9. Chance B, Schoener B, Oshino R, Itshak F, Nakase Y (1979) Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals. J Biol Chem 254(11):4764-4771
10. Dearling JLJ, Flynn AA, Sutcliffe-Goulden J, Petrie IA, Boden R, Green AJ, Boxer GM, Begent RHJ, Pedley RB (2004) Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J Nucl Med 45(1):101-107
11. Freund A, Chauveau C, Brouillet JP, Lucas A, Lacroix M, Licznar A, Vignon F, Lazennec G (2003) IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene 22(2):256-265
12. Gu Y, Qian Z, Chen J, Blessington D, Ramanujam N, Chance B (2002) High-resolution three-dimensional scanning optical image system for intrinsic and extrinsic contrast agents in tissue. Rev Sci Instrum 73(1):172-178
13. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674
14. Heppner GH (1984) Tumor heterogeneity. Cancer Res 44(6):2259-2265
15. Heppner GH, Miller FR (1998) The cellular basis of tumor progression. Int Rev Cytol 177:1-56
16. Kallinowski F, Vaupel P, Runkel S, Berg G, Fortmeyer HP, Baessler KH, Wagner K, Mueller-Klieser W, Walenta S (1988) Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res 48(24 Pt 1):7264-7272
17. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11(5):325
18. Köster F, Engel J, Schally A, Hönig A, Schröer A, Seitz S, Hohla F, Ortmann O, Diedrich K, Buchholz S (2009) Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition. Breast Cancer Res Treat 116(2):273
19. Li LZ (2012) Imaging mitochondrial redox potential and its possible link to tumor metastatic potential. J Bioenerg Biomembr 44:645-653
20. Li LZ, Zhou R, Xu HN, Moon L, Zhong T, Kim EJ, Qiao H, Reddy R, Leeper D, Chance B, Glickson JD (2009a) Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci U S A 106(16):6608-6613
21. Li LZ, Xu HN, Ranji M, Nioka S, Chance B (2009b) Mitochondrial redox imaging for cancer diagnostic and therapeutic studies. J Innov Optical Health Sci 2:325-341
22. Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K (2010) Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 16(3):876-887
23. Pedley RB, Hill SA, Boxer GM, Flynn AA, Boden R, Watson R, Dearling J, Chaplin DJ, Begent RH (2001) Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate. Cancer Res 61(12):4716-4722
24. Quistorff B, Haselgrove JC, Chance B (1985) High spatial resolution readout of 3-D metabolic organ structure: an automated, low-temperature redox ratioscanning instrument. Anal Biochem 148(2):389-400
25. Ranney D, Antich P, Dadey E, Mason R, Kulkarni P, Singh O, Chen H, Constantanescu A, Parkey R (2005) Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy. J Control Release 109(1-3):222-235
26. Thompson CB (2009) Metabolic enzymes as oncogenes or tumor suppressors. N Engl J Med 360(8):813-815
27. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029-1033
28. Vaupel P, Schlenger K, Knoop C, Hockel M (1991) Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51(12):3316-3322
29. Vaupel P, Hockel M, Mayer A (2007) Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal 9(8):1221-1235
30. Xu HN, Wu B, Nioka S, Chance B, Li LZ (2009a) Calibration of redox scanning for tissue samples. Proc of SPIE 7174:71742F1-71742F8
31. Xu HN, Zhou R, Nioka S, Chance B, Glickson JD, Li LZ (2009b) Histological basis of MR/optical imaging of human melanoma mouse xenografts spanning a range of metastatic potentials. Adv Exp Med Biol 645:247-253
32. Xu HN, Nioka S, Glickson JD, Chance B, Li LZ (2010) Quantitative mitochondrial redox imaging of breast cancer metastatic potential. J Biomed Opt 15(3):036010
33. Xu HN, Nioka S, Chance B, Zheng G, Li LZ (2011a) High-resolution simultaneous mapping of mitochondrial redox state and glucose uptake in human breast tumor xenografts. Adv Exp Med Biol 737:175-179
34. Xu HN, Nioka S, Chance B, Li LZ (2011b) Heterogeneity of mitochondrial redox state in premalignant pancreas in a PTEN null transgenic mouse model. Adv Exp Med Biol 701:207-213
35. Xu HN, Nioka S, Chance B, Li LZ (2012) 3-D high-resolution mapping of the heterogeneity in mitochondrial redox state of human breast tumor xenografts. Adv Exp Med Biol 737:169-174
36. Xu HN, Tchou J, Chance B, Li LZ (2013a) Imaging the redox states of human breast cancer core biopsies. Adv Exp Med Biol 765:343-349
37. Xu HN, Nioka S, Chance B, Li LZ (2013b) Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomarker Res 1:6
38. Zhang M, Zhang Z, Blessington D, Li H, Busch TM, Madrak V, Miles J, Chance B, Glickson JD, Zheng G (2003) Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. Bioconjug Chem 14(4):709-714
39. Zhang ZH, Li H, Liu Q, Zhou LL, Zhang M, Luo QM, Glickson J, Chance B, Zheng G (2004) Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers. Biosens Bioelectron 20(3):643-650